Pacira Biosciences
PCRX
#5486
Rank
NZ$2.65 B
Marketcap
NZ$66.46
Share price
0.00%
Change (1 day)
54.20%
Change (1 year)
Categories

Market capitalization of Pacira Biosciences (PCRX)

Market cap: NZ$2.65 Billion

As of November 2026 Pacira Biosciences has a market cap of NZ$2.65 Billion. This makes Pacira Biosciences the world's 5486th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Pacira Biosciences from 2011 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$2.65 B28.96%
2025NZ$2.05 B27.85%
2024NZ$1.60 B-35.07%
2023NZ$2.47 B-11.21%
2022NZ$2.79 B-28.89%
2021NZ$3.92 B8.91%
2020NZ$3.60 B27.82%
2019NZ$2.81 B6.62%
2018NZ$2.64 B1.38%
2017NZ$2.60 B49.52%
2016NZ$1.74 B-57.81%
2015NZ$4.13 B1.07%
2014NZ$4.09 B73.84%
2013NZ$2.35 B239.66%
2012NZ$0.69 B262.81%
2011NZ$0.19 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Zogenix
ZGNX
NZ$2.73 B 3.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
NZ$0.22 B-91.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
NZ$1.97 B-25.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
NZ$0.83 B-68.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
NZ$94.62 M-96.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
NZ$14.77 M-99.44%๐Ÿ‡บ๐Ÿ‡ธ USA